Product Information |
|
Registration Number |
BR-1464
|
Generic Name |
Trastuzumab deruxtecan
|
Brand Name |
Enhertu
|
Dosage Strength |
100 mg
|
Dosage Form |
Powder for Concentrate for Solution for Infusion (IV)
|
Classification |
Prescription (Rx) Drug
|
Packaging |
Type I amber glass vial and sealed with a fluoro-resin laminated butyl rubber stopper, and a polypropylene/ aluminum yellow flip-off crimp cap (Box of 1 vial)
|
Pharmacologic Category |
Human Epidermal Growth Factor Receptor 2 (HER2)
Inhibitor
|
Manufacturer |
Baxter Oncology GmbH
|
Country of Origin |
Germany
|
Trader |
|
Importer |
AstraZeneca Pharmaceuticals (Phils.), Inc.
|
Distributor |
|
Application Type |
Monitored Release
|
Issuance Date |
15 January 2024
|
Expiry Date |
15 January 2029
|